BioVie (BIVI) said late Monday that it has priced an offering of 1.96 million shares and warrants at a combined price of $1.53 per share and associated warrant, with a target gross proceeds of $3 million.
The company said the warrants to purchase up to 1.96 million shares will have an exercise price of $1.53 per share. The warrants will be immediately exercisable upon issuance for five years from the date of issuance.
The company said it will sell the securities in the offering and plans to use the net proceeds for working capital and general corporate purposes.
The sale is slated to be completed on Wednesday.
Shares of the company were down 51% in recent Tuesday premarket activity.
Price: 1.3700, Change: -1.43, Percent Change: -51.07
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。